Instruct patients to inform healthcare providers prior to any planned surgeries or procedures if they are taking Wegovy Adverse Reactions Most common adverse reactions (incidence 5%) are: nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis Drug Interactions The addition of Wegovy in patients treated with insulin has not been evaluated
Here is a definitive guide: Always discard if you see: Cloudiness or haziness (any degree) Visible particles, flakes, or sediment Brown, amber, or dark yellow color Dark red color (even in B12 formulations) Any color you were not told to expect Layering or separation within the solution Sticky or viscous consistency (should flow freely like water) Safe to use: Clear and colorless (all formulations) Clear with slight yellow tint (all formulations) Clear pink to light red (B12 formulations only) Uniform color throughout No visible particles Contact pharmacy before using if: Color seems different from the last vial of the same formulation Yellow tint has deepened since you started using the vial The solution looks different from what your pharmacy described You are unsure whether the product contains B12 When in doubt, throw it out
The flow rate was maintained at 1.0 mL/min
Globally, the UK accounted for 1.6% of the GLP-1 receptor agonist market
